Monday, April 21, 2025

Industry | 2017.07.17

Anpac Bio Wins Global Precision Medicine Industry Award: 2017 'Most Promising Cancer Screening Company'

Anpac Bio CEO Dr. Chris Yu proudly accepted the 2017 Global Precision Medicine Industry Award for "Most Promising Cancer Screening Company" from Award Judge, Professor Xu Chongren, Executive Vice President, School of Life Sciences at Peking University; at the China & America Precision Medicine Forum in Shanghai, China. The award recognized Anpac Bio\'s Cancer Differentiation Analysis liquid biopsy "diagnostics services excellence" in identifying early stage cancer. Photo courtesy of Anpac Bio. SACRAMENTO, Calif., July 17, 2017 /PRNewswire/ -- The Global Precision Medicine Industry Awards leadership named international life sciences corporation Anpac Bio-Medical Science Co., Ltd. ("Anpac Bio"), the 2017, "Most Promising Cancer Screening Company" award winner; in recognition of An...


 

For more information, please visit
http://www.prnewswire.com/news-releases/[...]reening-company-300488774.html

You need to login to post comments.

Feed last updated 2025/04/30 @6:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News